Previously, we identified EFhd2 as a novel protein associated with tau in the brains of JNPL3 mouse model and postmortem Alzheimer’s disease (AD) and frontotemporal lobar degeneration (FTLD) cases (Vega et al., 2008). Here, MAPT is linked to Alzheimer disease.